Publications:

Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.

Bmc Medicine

Zhou, Juan J; Bao, Minwei M; Gao, Guanghui G; Cai, Yiran Y; Wu, Lihong L; Lei, Lei L; Zhao, Jing J; Ji, Xianxiu X; Huang, Ying Y; Su, Chunxia C

Publication Date: 2022-07-29

Variant appearance in text: FLT4: 3331+8C>A

PubMed Link: 35902848

Variant Present in the following documents:

• 12916_2022_2444_MOESM1_ESM.xlsx, sheet 4

View BVdb publication page